期刊文献+

人参皂苷CK-乳铁蛋白固体分散体的构建及形成机制 被引量:1

Preparation of ginsenoside CK-lactoferrin solid dispersion and study on formation mechanism
下载PDF
导出
摘要 目的探讨人参皂苷CK-乳铁蛋白固体分散体(G-CK-Lf SD)的构建及形成机制。方法以乳铁蛋白(Lf)为载体、人参皂苷CK(G-CK)为主药,构建得到G-CK-Lf SD,采用差示扫描量热(DSC)、X射线衍射(XRD)、扫描电子显微镜(SEM)及体外溶出等方法对所得固体分散体进行表征,辅以分子模拟对其构建机制进行阐述。结果DSC和XRD分析结果显示,G-CK主要以无定形存在于固体分散体中;SEM结果表明,药物以无定形分散附着于Lf载体材料的表面;体外溶出度测定结果表明,G-CK-Lf SD分别在模拟人胃液(pH 1.2)和肠液(pH 6.8)环境下,均存在促进G-CK溶出的功能。分子对接阐述机制表明,Lf表面有6个主要位点与G-CK进行结合,结合能在6.5~8.5 kcal·mol^-1范围内。结论构建得到G-CK-Lf SD,其中G-CK主要以无定形存在,可有效促进其溶出,G-CK与Lf主要通过氢键和疏水作用结合,达到能量和形状的匹配,本研究结果为Lf在固体分散载体领域的应用提供了新思路。 Objective To investigate the preparation of ginsenoside CK-lactoferrin solid dispersion(G-CK-Lf SD)and study on the formation mechanism.Methods G-CK-Lf SD was constructed with lactoferrin(Lf)as the carrier and ginsenoside CK(G-CK)as the main drug.Differential scanning calorimetry(DSC),X-ray diffraction(XRD),scanning electron microscopy(SEM)and in vitro dissolution were used to characterize the solid dispersion,and the construction mechanism was described by molecular simulation.Results DSC and XRD analysis indicated that G-CK in the solid dispersion mainly existed in amorphous form.SEM showed that G-CK as amorphous form was attached to the surface of lactoferrin.The results of in vitro dissolution showed that G-CK-Lf SD could promote the dissolution of G-CK in simulated gastric juice(pH 1.2)and intestinal juice(pH 6.8),respectively.Molecular docking technology demonstrated that lactoferrin had 6 major points which could bind to G-CK.The binding energies were ranged from 6.5 to 8.5 kcal·mol^-1.Conclusion The G-CK-Lf SD,in which G-CK mainly existed as amorphous form,can effectively promote dissolution rate.The combination of G-CK and Lf was mainly because of hydrogen bonding and hydrophobic action,making the matching of energy and shape.Our study provides a new idea for applying Lf as carriers in solid dispersion research.
作者 蔡宁 杨青 金鑫 CAI Ning;YANG Qing;JIN Xin(Department of Pharmacy,Suqian First Hospital,Suqian 223800,China)
出处 《西北药学杂志》 CAS 2020年第5期696-701,共6页 Northwest Pharmaceutical Journal
基金 江苏省自然科学基金面上项目(编号:BK20171321)。
关键词 人参皂苷CK 乳铁蛋白 固体分散体 体外溶出度 机制 ginsenoside CK lactoferrin solid dispersion dissolution in vitro mechanism
  • 相关文献

参考文献11

二级参考文献59

  • 1张立坚,李宝红,邓亦峰.半边旗有效成分5F-泊洛沙姆固体分散体中5F的含量测定[J].西北药学杂志,2004,19(4):147-148. 被引量:2
  • 2鲍玉琳,刘卫东.几种中药注射液的过敏性研究[J].中国药师,2006,9(7):618-620. 被引量:15
  • 3Tiwari R,Pathak K.Nanostructured lipid carrier versussolid lipid nanoparticles of simvastatin:Comparative a-nalysis of characteristics,pharmacokinetics and tissueuptake[J].Int J Pharm,2011,415(1/2):232-243.
  • 4Jun SM,Kim MS,Kim JS,et a1.Preparation and charac-terization of simvastatin/hy-droxypropyl-b-cyclodextrininclusion complex using supercritical antisolvent(SAS)process[J].Eur J Pharm Biopharm,2007,66(3):413-421.
  • 5Silva TD,Arantes VT,Resende JA,et a1.Preparationand characterization of solid dispersion of simvastatin[J].Drug Dev Ind Pharm,2010,36(11):1348-1355.
  • 6Yosioka I, SugawaraT, Irnai K, et al. Soil bacterial hydrolysis leading to genuine aglyeonc V. Onginseaosides Rbl, Rb2 and Re of the ginsengrootsaponins.ChemPharmBull, 1972, 20 (11): 2418-2421.
  • 7Horikawa T. Diagnosis and management of drug-induced anaphylaxis. Arerugi, 2007, 56 (7): 655.
  • 8国家食品药品监督管理局组织编写.药物研究技术指导原则[中药,天然药物免疫毒性(过敏性、光变态反应)研究技术指导原则].北京:中国医药科技出版社,2005:3.
  • 9孟健,郑梁元.辛伐他汀微乳的制备及犬体内药物动力学[J].中国医药工业杂志,2007,38(11):772-775. 被引量:2
  • 10潘西海,赵丽.固体分散体中常用的载体[J].西北药学杂志,1997,12(6):277-278. 被引量:11

共引文献63

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部